NCT04926194已完成2 期
Decidual Stromal Cells (DSC) in Treatment of Steroid-Refractory Graft-vs-host Disease in a Recipient of Matched Related Donor Allogeneic Hematopoietic Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 1
- 试验地点
- 2
- 主要终点
- Eastern Cooperative Oncology Group Performance Status Score
研究概览
简要总结
This is a single participant study of decidual stromal cells (DSC) for the treatment of steroid refractory graft-versus-host disease (GVHD) in a patient with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN).
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Eastern Cooperative Oncology Group Performance Status Score
时间窗: 6 weeks
Bilirubin levels
时间窗: 6 weeks
C-reactive protein levels
时间窗: 6 weeks
Aspartate Transaminase levels
时间窗: 6 weeks
Alkaline phosphatase levels
时间窗: 6 weeks
Karnofsky Performance Score
时间窗: 6 weeks
Graft-Versus-Host Disease Severity
时间窗: 6 weeks
By grade
Alanine aminotransferase levels
时间窗: 6 weeks
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
终止
1 期
se of mesenchymal stromal cells for Graft-versus-host disease after stem cell transplantatioGraft vs Host DiseaseT86.0RBR-7s99ksfHospital de Clínicas da Universidade Federal do Paraná - HCUFPR
已完成
不适用
Mesenchymal stromal cells for the treatment of acute graft versus host diseaseSteroid refractory acute graft versus host disease after hematopoietic stem cell transplantation or donor lymphocyte infusionInjury, Occupational Diseases, PoisoningBone-marrow transplant rejectionISRCTN18091201Hematology and Oncology Research Association of Lithuania (Hematologijos ir onkologijos tyreju asociacija LTU)45
已完成
4 期
Dysphagia Following Anterior Cervical Spine Surgery; Single Dose Steroid vs Saline (DysDexVSSal)DysphagiaNCT03711474West Virginia University78
Unknown
1 期
Decidual Stromal Cells as Treatment for Acute Graft Versus Host Disease, a Phase 1-2 StudyGraft vs Host DiseaseNCT02172937Karolinska Institutet50
进行中（未招募）
1 期
Immunotherapeutic Rescue of steroidogenic function in autoimmune Addison’s Disease (RAD): Pilot study - Rescue of Addison's Disease (RAD)Autoimmune Addison's disease (adrenocortical failure)MedDRA version: 9.1Level: HLTClassification code 10001343Term: Adrenal cortical hypofunctionsEUCTR2007-003062-18-GBewcastle upon Tyne Hospitals NHS Trust10